These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 26406419)
1. RAD51C mutation screening in high-risk patients from Serbian hereditary breast/ovarian cancer families. Krivokuca A; Yanowski K; Rakobradovic J; Benitez J; Brankovic-Magic M Cancer Biomark; 2015; 15(6):775-81. PubMed ID: 26406419 [TBL] [Abstract][Full Text] [Related]
2. Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan. Rashid MU; Muhammad N; Faisal S; Amin A; Hamann U Breast Cancer Res Treat; 2014 Jun; 145(3):775-84. PubMed ID: 24800917 [TBL] [Abstract][Full Text] [Related]
3. Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer. Jønson L; Ahlborn LB; Steffensen AY; Djursby M; Ejlertsen B; Timshel S; Nielsen FC; Gerdes AM; Hansen TV Breast Cancer Res Treat; 2016 Jan; 155(2):215-22. PubMed ID: 26740214 [TBL] [Abstract][Full Text] [Related]
4. RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families. Blanco A; Gutiérrez-Enríquez S; Santamariña M; Montalban G; Bonache S; Balmaña J; Carracedo A; Diez O; Vega A Breast Cancer Res Treat; 2014 Aug; 147(1):133-43. PubMed ID: 25086635 [TBL] [Abstract][Full Text] [Related]
5. Germline mutations in RAD51C in Jewish high cancer risk families. Kushnir A; Laitman Y; Shimon SP; Berger R; Friedman E Breast Cancer Res Treat; 2012 Dec; 136(3):869-74. PubMed ID: 23117857 [TBL] [Abstract][Full Text] [Related]
6. Mutation screening of RAD51C in high-risk breast and ovarian cancer families. Lu W; Wang X; Lin H; Lindor NM; Couch FJ Fam Cancer; 2012 Sep; 11(3):381-5. PubMed ID: 22476429 [TBL] [Abstract][Full Text] [Related]
7. Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Thompson ER; Boyle SE; Johnson J; Ryland GL; Sawyer S; Choong DY; kConFab ; Chenevix-Trench G; Trainer AH; Lindeman GJ; Mitchell G; James PA; Campbell IG Hum Mutat; 2012 Jan; 33(1):95-9. PubMed ID: 21990120 [TBL] [Abstract][Full Text] [Related]
8. Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer. Zheng Y; Zhang J; Hope K; Niu Q; Huo D; Olopade OI Breast Cancer Res Treat; 2010 Dec; 124(3):857-61. PubMed ID: 20697805 [TBL] [Abstract][Full Text] [Related]
9. CHEK2 1100delC and Del5395bp mutations in BRCA-negative individuals from Serbian hereditary breast and ovarian cancer families. Krivokuca A; Dobricic J; Brankovic-Magic M J BUON; 2013; 18(3):594-600. PubMed ID: 24065469 [TBL] [Abstract][Full Text] [Related]
10. Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility. Vuorela M; Pylkäs K; Hartikainen JM; Sundfeldt K; Lindblom A; von Wachenfeldt Wäppling A; Haanpää M; Puistola U; Rosengren A; Anttila M; Kosma VM; Mannermaa A; Winqvist R Breast Cancer Res Treat; 2011 Dec; 130(3):1003-10. PubMed ID: 21750962 [TBL] [Abstract][Full Text] [Related]
11. RAD51C germline mutations in breast and ovarian cancer cases from high-risk families. Clague J; Wilhoite G; Adamson A; Bailis A; Weitzel JN; Neuhausen SL PLoS One; 2011; 6(9):e25632. PubMed ID: 21980511 [TBL] [Abstract][Full Text] [Related]
12. Genetic testing for RAD51C mutations: in the clinic and community. Sopik V; Akbari MR; Narod SA Clin Genet; 2015 Oct; 88(4):303-12. PubMed ID: 25470109 [TBL] [Abstract][Full Text] [Related]
13. Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families. Osorio A; Endt D; Fernández F; Eirich K; de la Hoya M; Schmutzler R; Caldés T; Meindl A; Schindler D; Benitez J Hum Mol Genet; 2012 Jul; 21(13):2889-98. PubMed ID: 22451500 [TBL] [Abstract][Full Text] [Related]
14. Germline RAD51C mutations in ovarian cancer susceptibility. Coulet F; Fajac A; Colas C; Eyries M; Dion-Minière A; Rouzier R; Uzan S; Lefranc JP; Carbonnel M; Cornelis F; Cortez A; Soubrier F Clin Genet; 2013 Apr; 83(4):332-6. PubMed ID: 22725699 [TBL] [Abstract][Full Text] [Related]
15. Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic. Janatova M; Soukupova J; Stribrna J; Kleiblova P; Vocka M; Boudova P; Kleibl Z; Pohlreich P PLoS One; 2015; 10(6):e0127711. PubMed ID: 26057125 [TBL] [Abstract][Full Text] [Related]
16. BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer. Wong MW; Nordfors C; Mossman D; Pecenpetelovska G; Avery-Kiejda KA; Talseth-Palmer B; Bowden NA; Scott RJ Breast Cancer Res Treat; 2011 Jun; 127(3):853-9. PubMed ID: 21409391 [TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of RAD51C and RAD51D genes in hereditary breast and ovarian cancer families from Murcia (southeastern Spain). Sánchez-Bermúdez AI; Sarabia-Meseguer MD; García-Aliaga Á; Marín-Vera M; Macías-Cerrolaza JA; Henaréjos PS; Guardiola-Castillo V; Peña FA; Alonso-Romero JL; Noguera-Velasco JA; Ruiz-Espejo F Eur J Med Genet; 2018 Jun; 61(6):355-361. PubMed ID: 29409816 [TBL] [Abstract][Full Text] [Related]
18. Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer. Li N; McInerny S; Zethoven M; Cheasley D; Lim BWX; Rowley SM; Devereux L; Grewal N; Ahmadloo S; Byrne D; Lee JEA; Li J; Fox SB; John T; Antill Y; Gorringe KL; James PA; Campbell IG J Natl Cancer Inst; 2019 Dec; 111(12):1332-1338. PubMed ID: 30949688 [TBL] [Abstract][Full Text] [Related]
19. Germline mutation in the RAD51B gene confers predisposition to breast cancer. Golmard L; Caux-Moncoutier V; Davy G; Al Ageeli E; Poirot B; Tirapo C; Michaux D; Barbaroux C; d'Enghien CD; Nicolas A; Castéra L; Sastre-Garau X; Stern MH; Houdayer C; Stoppa-Lyonnet D BMC Cancer; 2013 Oct; 13():484. PubMed ID: 24139550 [TBL] [Abstract][Full Text] [Related]
20. The RAD51C exonic splice-site mutations c.404G>C and c.404G>T are associated with familial breast and ovarian cancer. Neidhardt G; Becker A; Hauke J; Horváth J; Bogdanova Markov N; Heilmann-Heimbach S; Hellebrand H; Thiele H; Altmüller J; Nürnberg P; Meindl A; Rhiem K; Blümcke B; Wappenschmidt B; Schmutzler RK; Hahnen E Eur J Cancer Prev; 2017 Mar; 26(2):165-169. PubMed ID: 27622768 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]